Watson Pharmaceuticals, Inc. v. Schwetz

U.S. Court of Appeals for the Federal Circuit May 20, 2002

Watson Pharmaceuticals, Inc. v. Schwetz, 38 F. App'x 578 (Fed. Cir. 2002)

Opinion of the Court

ON MOTION

ORDER

Bristol-Myers Squibb Co., Watson Pharmaceuticals, Inc. and Danbury Phar-macal, Inc. move jointly to voluntarily dismiss with prejudice. The Acting Principal Deputy Commissioner consents.

Upon consideration thereof,

IT IS ORDERED THAT:

(1) The unopposed motion to dismiss is granted.

(2) The motion to transfer is moot.

(3) All sides shall bear their own costs.

Reference

Full Case Name: WATSON PHARMACEUTICALS, INC. and Danbury Pharmacal, Inc. v. Bernard A. SCHWETZ, D.V.M, Ph.D, Acting Principal Deputy Commissioner, U.S. Food and Drug Administration, and Bristol-Myers Squibb Company
Status: Published